Contact
Social
Category
Primary
cancer · embed-ft 0.51
Tree path
Medical Health › Diseases and Conditions › Cancer
Group (tier-1)
Tech stack
AI readiness
AI training policy
reserved
AI-bot protection
Blocked AI bots
AI files
Evidence
robots:Bytespider+CCBot+ClaudeBot+Google-Extended+GPTBot+Meta-ExternalAgent+Amazonbot+Applebot-Extended
Compliance (GEO / GDPR)
TLD
Overview
Title
REVEAL-ND NPM1 AML Clinical Trial | Revumenib Study
Description
The REVEAL-ND NPM1 AML clinical trial is evaluating revumenib in combination with intensive chemotherapy for patients with newly diagnosed acute myeloid leukemia with an NPM1 mutation.
Final URL
Language
en (html)
Scanned at
2026-06-26 12:36:37